From the Journals

Many Patients With Cancer Visit EDs Before Diagnosis


 

FROM CMAJ

‘Unpacking the Data’

The current findings also are consistent with those of an International Cancer Benchmarking Partnership study that was published in 2022 in The Lancet Oncology, said Erika Nicholson, MHS, vice president of cancer systems and innovation at the Canadian Partnership Against Cancer. The latter study analyzed cancer registration and linked hospital admissions data from 14 jurisdictions in Australia, Canada, Denmark, New Zealand, Norway, and the United Kingdom.

“We see similar trends in terms of people visiting EDs and being diagnosed through EDs internationally,” Nicholson said. “We’re working with partners to put in place different strategies to address the challenges” that this phenomenon presents in terms of improving screening and follow-up care.

“Cancer is not one disease, but many diseases,” she said. “They present differently. We’re focused on really unpacking the data and understanding them.”

All this research highlights the need for more services and personnel to address cancer, including people who are trained to help patients cope after getting concerning news through emergency care, she said.

“That means having a system that fully supports you and helps you navigate through that diagnostic process,” Nicholson said. Addressing the added challenges for patients who don’t have secure housing is a special need, she added.

This study was supported by the Canadian Institutes of Health Research (CIHR). Grewal reported receiving grants from CIHR and the Canadian Association of Emergency Physicians. Nicholson reported no relevant financial relationships.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

AACR Cancer Progress Report: Big Strides and Big Gaps
MDedge Dermatology
Does Medicare Advantage Offer Higher-Value Chemotherapy?
MDedge Dermatology
Popular Weight Loss Drugs Now for Patients With Cancer?
MDedge Dermatology
‘Cancer Doesn’t Wait’: How Prior Authorization Harms Care
MDedge Dermatology
The New Cancer Stats Might Look Like a Death Sentence. They Aren’t.
MDedge Dermatology
Risk Assessment Tool Can Help Predict Fractures in Cancer
MDedge Dermatology
Is It Possible To Treat Patients You Dislike?
MDedge Dermatology
Cannabis in Cancer: What Oncologists and Patients Should Know
MDedge Dermatology
Cancer’s Other Toll: Long-Term Financial Fallout for Survivors
MDedge Dermatology
Plasma Omega-6 and Omega-3 Fatty Acids Inversely Associated With Cancer
MDedge Dermatology